Dr Mikyung (Kelly) Seo, MSc, PhD

Profile

I am a health economist with the Health Economics and Policy Research Unit (HEPRU) at the Wolfson Institute of Population Health, Queen Mary University of London (QMUL). I hold honorary academic positions at both the University of Cambridge and Imperial College London and joined QMUL in 2024 as a senior health economist, bringing experience from my previous roles at these institutions. With a strong background in health economics and health services research, I have contributed to international organizations, including the International Labour Organization (ILO) in Geneva and the International Vaccine Institute (IVI) in Seoul, and have worked in consultancy within health economics and policy. I earned my PhD in Health Economics from the London School of Hygiene and Tropical Medicine (LSHTM) and an MSc in Health Policy, Planning, and Financing from the London School of Economics and Political Science (LSE).

At WIPU, I lead projects focused on assessing the cost-effectiveness of health innovations, including pharmaceuticals, diagnostics and care pathways in primary and secondary healthcare, aimed at facilitating their integration and adoption into the UK National Health Services. My work encompasses all stages of study design—collecting health economic data from patients alongside clinical trials—and extends through data analysis, synthesis, and linkage with external datasets.

Research

Research Interests:

My research interests are primarily in the cost-effectiveness of interventions to improve public health across a range of health interventions, disease areas, and population groups.

My research areas include:

• Economic evaluations.
• Discrete choice experiment (DCE). 
• Decision-analytic modelling.
• Health technology assessment (HTA).
• Survival analysis.
• Care pathway analysis.
• Value of information analysis.
• Econometrics.
• Systematic literature review and meta-analysis.
• Budget impact analysis.

Publications

Featured publications

 

Kenseth A., Kantorova D., Seo M.K., Aas E., Cairns J., Kerr D., Askautrud H., Jacobsen J.E., 2024. "Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?," PharmacoEconomics (2024), Vol. 42(6), pages: 679-691.

Angelis A., Harker M., Cairns J., Seo M.K., et al. (2023). “The evolving nature of Health Technology Assessment: a critical appraisal of NICE’s new methods manual,” Value In Health (2023), Vol: 26, Pages:1503-1509.

Angelis A., Harker M., Cairns J., Seo M.K., et al. (2023). “The evolving nature of Health Technology Assessment: a critical appraisal of NICE’s new methods manual,” Value In Health (2023), Vol: 26, Pages:1503-1509.

Seo M.K., Strong M. (2021). “A practical guide to modelling and conducting a cost-effectiveness analysis of companion biomarker tests for targeted therapies using R: Tutorial paper,” Pharmacoeconomics, Vol: 39, Pages: 1373-81.

Seo M.K., Cairns J. (2018). “Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer,” PLOS One, Vol:13, ISSN:1932-6203, Pages:1-23.